David C. Myles
CH. DISCOV. & NON-CLIN DEV OFF · 1 filing · Latest: Feb 2, 2026
Olema Pharmaceuticals, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
OLMA | Myles David C. | — | Jan 14, 2026 | Proposed Sale | $28.87 | 50,000 | $1.4M | — | |
OLMA | Myles David C. | — | Jan 13, 2026 | Proposed Sale | $27.60 | 50,000 | $1.4M | — | |
OLMA | Myles David C. | — | Jan 12, 2026 | Proposed Sale | $28.34 | 10,000 | $283.4K | — | |
OLMA | Myles David C. | — | Dec 19, 2025 | Proposed Sale | $30.46 | 51,000 | $1.6M | — | |
OLMA | Myles David C. | — | Dec 11, 2024 | Proposed Sale | $8.68 | 13,614 | $118.2K | — | |
OLMA | Myles David C. | — | Dec 10, 2024 | Proposed Sale | $9.38 | 12,452 | $116.7K | — |